Director/PDMR Shareholding

Primary Health Properties PLC
20 May 2024

Primary Health Properties PLC

("PHP" or the "Company"),



Director/PDMR Shareholding



The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.


Details of person discharging managerial responsibilities/person closely associated



Harry Hyman



Reason for notification



Non-executive Chair


Initial notification/amendment

Initial notification



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor





Primary Health Properties PLC






Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


Description of the financial instrument

Ordinary shares of 12.5p



Nature of the transaction

Purchase by ISA under dividend re-investment plan



Price(s) and volume(s)



£ 0.962



Aggregated volume price

Single transaction




Date of transaction

17 May 2024



Place of transaction

London Stock Exchange (xlon)



For further information

Primary Health Properties PLC


Toby Newman, Company Secretary & Chief Legal Officer

+44(0) 7729 047 959


Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings